As part of the deal, KKR will purchase up to 54 per cent of HCG's equity from CVC Asia V at a price of INR 445 per share.

As part of the transaction, KKR will acquire up to 54 per cent of equity in HCG from CVC Asia V at a purchase price of Rs 445 ...

KKR said it has agreed to acquire a controlling stake in cancer treatment chain HealthCare Global Enterprises Ltd (HCG) from ...

KKR & Co Inc. is set to acquire a majority stake in India’s Healthcare Global Enterprises Ltd. from CVC Capital Partners at a ...

Boosted by the development, Healthcare Global shares rose 3.5% to ₹517.85 in early trade today, while the market ...

As part of the transaction, KKR will acquire up to 54 per cent of equity in HCG from CVC Asia V at a purchase price of Rs 445 ...

American private equity fund KKR will acquire a 51% stake in HealthCare Global Enterprises for Rs 3,203 crore, making an open ...

ICICI Securities recommended hold rating on HealthCare Global Enterprises with a target price of Rs 525 in its research ...

US private equity firm KKR & Co. will acquire a majority stake in HealthCare Global Enterprises Ltd. for around Rs 3,350 ...

KKR & CVC Asia V reach definitive agreements to become the largest shareholder in HCG for $400M, with SEBI's Takeover ...

KKR, a leading global investment firm, and Healthcare Global Enterprises (BSE: 539787; NSE: HCG; “HCG”), a leading healthcare organization in India, today announced the signing of definitive ...

HCG is one of India’s largest oncology hospital chains. HCG operates 25 medical care centers across 19 cities including 2,500 beds, nearly 100 operating theaters and 40 linear accelerator machines (LI ...